Purpose
to develop and test an attenuated influenza virus vector with an adjuvant that stimulates natural killer cells to induce robust immunity at mucosal surfaces to HIV, which is important in both prevention and control of infection.
Grantee
Division
Global Health
Date
NOVEMBER 2009
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
18
Grantee location
Melbourne, Victoria, Australia
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.